Study links cord blood lipid levels to early ADHD and autism symptoms

Mi­rati Ther­a­peu­tics is once again at­tract­ing buy­out in­ter­est, this time al­leged­ly from Sanofi, ac­cord­ing to a re­port from Bloomberg on Thurs­day. The biotech’s shares $MRTX surged by

No­vo Nordisk has inked an up to $1.46 bil­lion deal with the biotech Neo­morph to de­vel­op “mol­e­c­u­lar glues,” a field that’s see­ing a flur­ry of

Bio­phar­ma com­pa­nies whose Covid-19 drugs and vac­cines cre­at­ed an un­prece­dent­ed flood of new rev­enue and prof­its are now pulling back on the huge in­vest­ments they